Zymeworks Takes Poison Pill to Block Hostile Bid
Related Posts
OnlyFans Explores $3.5 Billion Sale to Architect Capital in Landmark Creator Platform Deal
null OnlyFans, the British subscription platform that revolutionized creator monetization, is in preliminary discussions to sell a 60% stake to San Francisco-based private investment firm Architect...
Musk Faces Renewed SEC Scrutiny Over Twitter Stock Purchases in Ongoing Insider Trading Suit
Elon Musk's 2022 acquisition of Twitter, now X Corp, continues to draw regulatory fire from the U.S. Securities and Exchange Commission. On January 28, 2026, a federal appeals court in the Ninth...
GameStop CEO’s ‘Monumental’ Secret Plan
GameStop CEO Ryan Cohen outlined a strategy to transform the video game retailer into a $100 billion powerhouse through a major acquisition in the consumer or retail sectors, deploying the company's...
Abu Dhabi Royal Takes 49% Stake in Trump Family’s World Liberty Financial for $500 Million Amid Conflict Scrutiny
A UAE royal family entity, backed by Sheikh Tahnoon bin Zayed Al Nahyan, acquired a 49% equity stake in World Liberty Financial, the Trump family's flagship DeFi platform, for $500 million just four...